Leuprolide

Breastfeeding
  • TRADE NAMES: Carcinil; Eligard (Sanofi-Aventis); Enantone; Leuprorelin; Lucrin; Lupron (TAP); Lupron Depot-Ped (AbbVie); Procren Depot; Procrin; Tapros; Viadur (Bayer)
  • INDICATIONS: Prostate carcinoma, endometriosis
  • SYNONYM: leuprorelin
  • CLASS: Gonadotropin-releasing hormone (GnRH) agonist
  • HALF-LIFE: 3–4 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

None known

PREGNANCY CATEGORY: X

Our database has 56 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GENITOURINARY.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 08/01/2022

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top